Cadrenal Therapeutics, Inc. (CVKD) Tops Q3 EPS by 8c

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q3 EPS of ($1.31), $0.08 better than the analyst estimate of ($1.39).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.

You May Also Be Interested In

• Nomura/Instinet Downgrades RHB Bank (RHBBANK:MK) to Neutral
• Goldman Sachs Starts GenFleet Therapeutics Shanghai (2595:HK) at Buy
• Blue Owl leads $2.4 billion debt deal for Iren data center